MicroPort Scientific Toekomstige groei

Future criteriumcontroles 1/6

MicroPort Scientific zal naar verwachting groeien in winst en omzet met respectievelijk 72.7% en 15.3% per jaar. De winst per aandeel zal naar verwachting groeien met 72% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting -19.8% zijn.

Belangrijke informatie

72.7%

Groei van de winst

72.0%

Groei van de winst per aandeel

Medical Equipment winstgroei	39.9%
Inkomstengroei	15.3%
Toekomstig rendement op eigen vermogen	-19.8%
Dekking van analisten	Good
Laatst bijgewerkt	08 Nov 2024

Recente toekomstige groei-updates

Recent updates

MicroPort Scientific Corporation's (HKG:853) Intrinsic Value Is Potentially 99% Above Its Share Price

Oct 23

Improved Revenues Required Before MicroPort Scientific Corporation (HKG:853) Shares Find Their Feet

Sep 26

We Think MicroPort Scientific (HKG:853) Has A Fair Chunk Of Debt

May 06

Little Excitement Around MicroPort Scientific Corporation's (HKG:853) Revenues As Shares Take 25% Pounding

Apr 16

Is There An Opportunity With MicroPort Scientific Corporation's (HKG:853) 39% Undervaluation?

Mar 20

MicroPort Scientific Corporation (HKG:853) Held Back By Insufficient Growth Even After Shares Climb 30%

Feb 26

MicroPort Scientific Corporation (HKG:853) Shares Could Be 42% Below Their Intrinsic Value Estimate

Dec 11

Does MicroPort Scientific (HKG:853) Have A Healthy Balance Sheet?

Oct 17

MicroPort Scientific Corporation's (HKG:853) Intrinsic Value Is Potentially 45% Above Its Share Price

Sep 08

Is MicroPort Scientific Corporation (HKG:853) Expensive For A Reason? A Look At Its Intrinsic Value

Jul 26

What Kind Of Investors Own Most Of MicroPort Scientific Corporation (HKG:853)?

Dec 22

What Did MicroPort Scientific's (HKG:853) CEO Take Home Last Year?

Nov 17

Winst- en omzetgroeiprognoses

SEHK:853 - Toekomstschattingen van analisten en financiële gegevens uit het verleden (USD Millions )
Datum	Inkomsten	Inkomsten	Vrije kasstroom	Geldmiddelen uit operationele activiteiten	Gem. Aantal analisten
12/31/2026	1,577	-17	165	56	5
12/31/2025	1,297	-158	108	-213	8
12/31/2024	1,111	-211	-173	-192	6
6/30/2024	1,027	-412	-269	-102	N/A
3/31/2024	989	-445	-350	-167	N/A
12/31/2023	951	-478	-431	-232	N/A
9/30/2023	935	-439	-513	-288	N/A
6/30/2023	918	-401	-595	-345	N/A
3/31/2023	880	-419	-598	-344	N/A
12/31/2022	841	-437	-601	-343	N/A
9/30/2022	820	-410	-603	-328	N/A
6/30/2022	799	-384	-605	-313	N/A
3/31/2022	789	-330	-555	-285	N/A
12/31/2021	779	-276	-505	-258	N/A
9/30/2021	753	-246	-382	-198	N/A
6/30/2021	726	-216	-260	-138	N/A
3/31/2021	688	-204	-202	-81	N/A
12/31/2020	649	-191	-144	-23	N/A
9/30/2020	678	-138	-119	0	N/A
6/30/2020	708	-85	-93	24	N/A
3/31/2020	751	-19	-91	25	N/A
12/31/2019	793	46	-89	26	N/A
9/30/2019	773	56	-79	35	N/A
6/30/2019	752	66	-70	44	N/A
3/31/2019	711	45	-38	64	N/A
12/31/2018	669	24	-6	84	N/A
9/30/2018	603	23	4	95	N/A
6/30/2018	537	21	13	106	N/A
3/31/2018	490	20	N/A	102	N/A
12/31/2017	444	19	N/A	97	N/A
9/30/2017	426	25	N/A	93	N/A
6/30/2017	409	31	N/A	89	N/A
3/31/2017	399	22	N/A	86	N/A
12/31/2016	390	14	N/A	83	N/A
9/30/2016	387	5	N/A	68	N/A
6/30/2016	383	-4	N/A	54	N/A
3/31/2016	379	-8	N/A	42	N/A
12/31/2015	376	-12	N/A	31	N/A
9/30/2015	369	-32	N/A	29	N/A
6/30/2015	363	-52	N/A	28	N/A
3/31/2015	359	-56	N/A	23	N/A
12/31/2014	355	-59	N/A	18	N/A
9/30/2014	312	-30	N/A	24	N/A
6/30/2014	268	-1	N/A	31	N/A
3/31/2014	210	12	N/A	44	N/A
12/31/2013	152	24	N/A	58	N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: De verwachting is dat 853 de komende 3 jaar verliesgevend zal blijven.

Winst versus markt: De verwachting is dat 853 de komende 3 jaar verliesgevend zal blijven.

Hoge groeiwinsten: De verwachting is dat 853 de komende 3 jaar verliesgevend zal blijven.

Omzet versus markt: De omzet van 853 ( 15.3% per jaar) zal naar verwachting sneller groeien dan de markt Hong Kong ( 7.8% per jaar).

Hoge groei-inkomsten: De omzet van 853 ( 15.3% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Er wordt voorspeld dat 853 binnen 3 jaar verliesgevend zal zijn.

MicroPort Scientific Toekomstige groei

Future criteriumcontroles 1/6

Belangrijke informatie

Recente toekomstige groei-updates

Consensus EPS estimates fall by 34%

Microport Scientific Corporation Provides Consolidated Earnings Guidance for the Six Months Ended June 30, 2023

No longer forecast to breakeven

Consensus forecasts updated

MicroPort Scientific Corporation Provides Consolidated Earnings Guidance for the Six Months Ended June 30, 2022

Consensus forecasts updated

Recent updates

MicroPort Scientific Corporation's (HKG:853) Intrinsic Value Is Potentially 99% Above Its Share Price

New minor risk - Share price stability

First half 2024 earnings released: US$0.053 loss per share (vs US$0.089 loss in 1H 2023)

Improved Revenues Required Before MicroPort Scientific Corporation (HKG:853) Shares Find Their Feet

New minor risk - Profitability

MicroPort Scientific Corporation to Report First Half, 2024 Results on Aug 30, 2024

MicroPort Scientific Corporation Announces Firesorb Bioresorbable Coronary Scaffold System Obtained Approval for Marketing from the NMPA

MicroPort Scientific Corporation Announces Firesorb Bioresorbable Coronary Scaffold System Obtained Approval for Marketing from the NMPA

Now 44% undervalued after recent price drop

Now 23% undervalued after recent price drop

Microport Scientific Corporation Announces Retirement of Non-Executive Directors

Now 20% undervalued after recent price drop

We Think MicroPort Scientific (HKG:853) Has A Fair Chunk Of Debt

Little Excitement Around MicroPort Scientific Corporation's (HKG:853) Revenues As Shares Take 25% Pounding

MicroPort Scientific Corporation, Annual General Meeting, May 22, 2024

Full year 2023 earnings released: US$0.26 loss per share (vs US$0.24 loss in FY 2022)

Is There An Opportunity With MicroPort Scientific Corporation's (HKG:853) 39% Undervaluation?

MicroPort Scientific Corporation to Report Fiscal Year 2023 Results on Mar 28, 2024

Consensus EPS estimates fall by 34%

MicroPort Scientific Corporation (HKG:853) Held Back By Insufficient Growth Even After Shares Climb 30%

MicroPort Scientific Corporation (HKG:853) Shares Could Be 42% Below Their Intrinsic Value Estimate

New minor risk - Share price stability

Now 40% undervalued after recent price drop

MicroPort Scientific Corporation Announces Appointment of Peng Bo as Non-Executive Director and Member of the Strategic Committee

Does MicroPort Scientific (HKG:853) Have A Healthy Balance Sheet?

MicroPort Scientific Corporation's (HKG:853) Intrinsic Value Is Potentially 45% Above Its Share Price

First half 2023 earnings released: US$0.089 loss per share (vs US$0.11 loss in 1H 2022)

MicroPort Scientific Corporation to Report First Half, 2023 Results on Aug 30, 2023

Microport Scientific Corporation Provides Consolidated Earnings Guidance for the Six Months Ended June 30, 2023

Now 23% undervalued after recent price drop

MicroPort Scientific Corporation Announces Board Changes

Is MicroPort Scientific (HKG:853) Using Debt Sensibly?

Independent Non-Executive Director recently sold HK$2.1m worth of stock

MicroPort Scientific Corporation, Annual General Meeting, Jun 19, 2023

A Look At The Fair Value Of MicroPort Scientific Corporation (HKG:853)

Independent Non-Executive Director recently sold HK$5.3m worth of stock

No longer forecast to breakeven

Full year 2022 earnings: EPS and revenues miss analyst expectations

Microport Scientific Corporation Announces That Hiroshi Shirafuji Has Accepted the Invitation to Act as the Honorary Chairman

Less than half of directors are independent

First half 2022 earnings released: US$0.11 loss per share (vs US$0.05 loss in 1H 2021)

Consensus forecasts updated

MicroPort Scientific Corporation Provides Consolidated Earnings Guidance for the Six Months Ended June 30, 2022

Is MicroPort Scientific (HKG:853) Weighed On By Its Debt Load?

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Less than half of directors are independent

Consensus forecasts updated

MicroPort Scientific Corporation, Annual General Meeting, Jun 23, 2022

Full year 2021 earnings: EPS exceeds analyst expectations

MicroPort Scientific Corporation Not to Recommend Final Dividend for the Year Ended 31 December 2021

MicroPort Scientific Corporation Provides Consolidated Earnings Guidance for the Full Year Ended December 31, 2021

Is MicroPort Scientific Corporation (HKG:853) Trading At A 33% Discount?

Now 22% undervalued after recent price drop

A Look At The Fair Value Of MicroPort Scientific Corporation (HKG:853)

MicroPort Scientific (HKG:853) Has Debt But No Earnings; Should You Worry?

First half 2021 earnings released: US$0.05 loss per share (vs US$0.039 loss in 1H 2020)

First half 2021 earnings released: US$0.05 loss per share (vs US$0.039 loss in 1H 2020)

Independent Non-Executive Director exercised options to buy HK$35m worth of stock.

Is MicroPort Scientific Corporation (HKG:853) Expensive For A Reason? A Look At Its Intrinsic Value

Upcoming dividend of HK$0.043 per share

Consensus EPS estimates fall to -US$0.035

MicroPort Scientific Corporation Proposes Final Dividend for the Year Ended 31 December 2020

Full year 2020 earnings released: US$0.11 loss per share (vs US$0.029 profit in FY 2019)

Full year 2020 earnings released: US$0.11 loss per share (vs US$0.029 profit in FY 2019)

New 90-day high: HK$55.10

New 90-day high: HK$42.20

What Kind Of Investors Own Most Of MicroPort Scientific Corporation (HKG:853)?

New 90-day high: HK$37.65

What Did MicroPort Scientific's (HKG:853) CEO Take Home Last Year?